{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:45:52Z","timestamp":1788353152405,"version":"build-2803163510"},"reference-count":94,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"publisher","award":["2016"],"award-info":[{"award-number":["2016"]}],"id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40620-017-0432-8","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T03:51:25Z","timestamp":1505879485000},"page":"719-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-2429","authenticated-orcid":false,"given":"Giacomo","family":"Garibotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Picciotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Verzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"issue":"3","key":"432_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","volume":"19","author":"JF Navarro-Gonz\u00e1lez","year":"2008","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez CJ (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19(3):433\u2013442","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"432_CR2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0272-6386(12)80393-3","volume":"21","author":"T Furuta","year":"1993","unstructured":"Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K (1993) The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21(5):480\u2013485","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"432_CR3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5):373\u201384","journal-title":"Nat Immunol"},{"issue":"1","key":"432_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneph.2015.175","volume":"12","author":"J Wada","year":"2016","unstructured":"Wada J, Makino H (2016) Innate immunity in diabetes and diabetic nephropathy. Nat Rev Nephrol 12(1):13\u201326","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"432_CR5","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1172\/JCI22832","volume":"115","author":"JC Leemans","year":"2005","unstructured":"Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S (2005) Renal-associated TLR2 mediates ischemia\/reperfusion injury in the kidney. J Clin Invest 115(10):2894\u20132903","journal-title":"J Clin Invest"},{"issue":"2","key":"432_CR6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2009.09.075","volume":"209","author":"WK Den Dekker","year":"2010","unstructured":"Den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ (2010) Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 209(2):314\u2013320","journal-title":"Atherosclerosis"},{"issue":"7","key":"432_CR7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1182\/blood-2012-02-404475","volume":"16","author":"J Fric","year":"2012","unstructured":"Fric J, Zelante T, Wong AY, Mertes A, Yu HB, Ricciardi-Castagnoli P (2012) NFAT control of innate immunity. Blood 16(7):1380\u20131389","journal-title":"Blood"},{"issue":"3","key":"432_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","volume":"18","author":"O Osborn","year":"2012","unstructured":"Osborn O, Olefsky JM (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 6 18(3):363\u2013374","journal-title":"Nat Med"},{"issue":"4","key":"432_CR9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000445754","volume":"6","author":"F Thameem","year":"2016","unstructured":"Thameem F, Puppala S, Farook VS, Kasinath BS, Blangero J, Duggirala R, Abboud HE (2016) Genetic variants in toll-Like receptor 4 gene and their association analysis with estimated glomerular filtration rate in mexican american families. Cardiorenal Med 6(4):301\u2013306","journal-title":"Cardiorenal Med"},{"issue":"3","key":"432_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1210\/er.2014-1100","volume":"36","author":"LA Velloso","year":"2015","unstructured":"Velloso LA, Folli F, Saad MJ (2015) TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation. Endocr Rev 36(3):245\u2013271","journal-title":"Endocr Rev"},{"key":"432_CR11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00125-009-1394-8","volume":"52","author":"S Devaraj","year":"2009","unstructured":"Devaraj S, Dasu MR, Park SH, Jialal I (2009) Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52:1665\u20131668","journal-title":"Diabetologia"},{"key":"432_CR12","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","volume":"292","author":"SJ Creely","year":"2007","unstructured":"Creely SJ, McTernan PG, Kusminski CM, Fisher fM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740\u2013E747","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"432_CR13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delm\u00e9e E, Cousin B, Sulpice T, Chamontin B, Ferri\u00e8res J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761\u20131772","journal-title":"Diabetes"},{"issue":"4","key":"432_CR14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4065\/83.4.460","volume":"83","author":"JK Baise Di","year":"2008","unstructured":"Di Baise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE (2008) Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 83(4):460\u2013469","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"432_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db09-0367","volume":"59","author":"NN Mehta","year":"2010","unstructured":"Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L, Tabita-Martinez J, Sellers KF, Rickels MR, Reilly MP (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59(1):172\u2013181","journal-title":"Diabetes"},{"issue":"8","key":"432_CR16","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00394-014-0817-6","volume":"54","author":"AP Moreira","year":"2015","unstructured":"Moreira AP, Alves RD, Teixeira TF, Macedo VS, De Oliveira LL, Costa NM, Bressan J, Do Carmo Gouveia Peluzio M, Mattes R, de C\u00e1ssia Gon\u00e7alves Alfenas R (2015) Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight\/obese men. Eur J Nutr. 54(8):1363\u20131370","journal-title":"Eur J Nutr"},{"key":"432_CR17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2337\/dc10-1676","volume":"34","author":"PJ Pussinen","year":"2011","unstructured":"Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34:392\u2013397","journal-title":"Diabetes Care"},{"issue":"8","key":"432_CR18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2337\/dc10-2197","volume":"34","author":"MI Lassenius","year":"2011","unstructured":"Lassenius MI, Pietil\u00e4inen KH, Kaartinen K, Pussinen PJ, Syrj\u00e4nen J, Forsblom C, P\u00f6rsti I, Rissanen A, Kaprio J, Mustonen J, Groop PH, Lehto M, FinnDiane Study Group (2011) Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care Aug;34(8):1809\u20131815","journal-title":"Diabetes Care"},{"key":"432_CR19","doi-asserted-by":"crossref","unstructured":"Boutagy NE, McMillan RP, Frisard MI, Hulver MW (2016) Metabolic endotoxemia with obesity: Is it real and is it relevant?. Biochimie124:11\u201320","DOI":"10.1016\/j.biochi.2015.06.020"},{"issue":"11","key":"432_CR20","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s10620-012-2242-0","volume":"57","author":"F Wang","year":"2012","unstructured":"Wang F, Zhang P, Jiang H, Cheng S (2012) Gut bacterial translocation contributes to microinflammation in experimental uremia. Dig Dis Sci 57(11):2856\u20132862","journal-title":"Dig Dis Sci"},{"issue":"1","key":"432_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mnfr.201500272","volume":"60","author":"V Apostolopoulos","year":"2016","unstructured":"Apostolopoulos V, de Courten MP, Stojanovska L, Blatch GL, Tangalakis K, de Courten B (2016) The complex immunological and inflammatory network of adipose tissue in obesity. Mol Nutr Food Res 60(1):43\u201357","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"432_CR22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10753-011-9374-9","volume":"35","author":"M Yang","year":"2012","unstructured":"Yang M, Gan H, Shen Q, Tang W, Du X, Chen D (2012) Proinflammatory CD14 + CD16 + monocytes are associated with microinflammation in patients with type 2 diabetes mellitus and diabetic nephropathy uremia. Inflammation 35(1):388\u2013396","journal-title":"Inflammation"},{"key":"432_CR23","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/db08-0564","volume":"57","author":"M Dasu","year":"2008","unstructured":"Dasu M, Devaraj S (2008) High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 57:3090\u20133098","journal-title":"Diabetes"},{"key":"432_CR24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","volume":"33","author":"MR Dasu","year":"2010","unstructured":"Dasu MR, Devaraj S, Park S, Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33:861\u2013868","journal-title":"Diabetes Care"},{"issue":"36","key":"432_CR25","doi-asserted-by":"crossref","first-page":"26602","DOI":"10.1074\/jbc.M601284200","volume":"8","author":"N Kamei","year":"2006","unstructured":"Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R, Kadowaki T (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 8(36):26602\u201326614","journal-title":"J Biol Chem"},{"issue":"6","key":"432_CR26","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","volume":"116","author":"H Kanda","year":"2006","unstructured":"Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116(6):1494\u20131505","journal-title":"J Clin Invest"},{"key":"432_CR27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","volume":"293","author":"M Yuan","year":"2001","unstructured":"Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk\u03b2. Science 293:1673\u20131677","journal-title":"Science"},{"issue":"6913","key":"432_CR28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi J, Tuncman G, Chang L, G\u00f6rg\u00fcn CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS (2002) A central role for JNK in obesity and insulin resistance. Nature 21 420(6913):333\u20136002","journal-title":"Nature"},{"key":"432_CR29","doi-asserted-by":"crossref","first-page":"35375","DOI":"10.1074\/jbc.M806480200","volume":"283","author":"J Zhang","year":"2008","unstructured":"Zhang J, Gao Z, Yin J, Quon MJ, Ye J (2008) S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-\u03b1 signaling through IKK2. J Biol Chem 283:35375\u201335382","journal-title":"J Biol Chem"},{"key":"432_CR30","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1074\/jbc.M109.076976","volume":"285","author":"Y Fan","year":"2010","unstructured":"Fan Y, Yu Y, Shi Y, Sun W, Xie M, Ge N, Mao R, Chang A, Xu G, Schneider MD, Zhang H, Fu S, Qin J, Yang J (2010) Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor \u03b1- and interleukin-1\u03b2-induced IKK\/NF-\u03baB and JNK\/AP-1 activation. J Biol Chem 285:5347\u20135360","journal-title":"J Biol Chem"},{"key":"432_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/en.2006-0692","volume":"148","author":"J Jager","year":"2007","unstructured":"Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF (2007) Interleukin-1\u03b2-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148:241\u2013251","journal-title":"Endocrinology"},{"key":"432_CR32","unstructured":"Boucher J1, Kleinridders A, Kahn CR (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol 1; 6"},{"key":"432_CR33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/diab.44.10.1239","volume":"44","author":"G Boden","year":"1995","unstructured":"Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239\u20131242","journal-title":"Diabetes"},{"key":"432_CR34","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2004-0224","volume":"89","author":"M Bajaj","year":"2004","unstructured":"Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA (2004) Sustained reduction in plasma free fatty acid levels improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab 89:4649\u20134655","journal-title":"J Clin Endocrinol Metab"},{"key":"432_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","volume":"106","author":"GI Shulman","year":"2000","unstructured":"Shulman GI (2000) Cellular mechanisms of insulin resistance. J Clin Invest 106:171\u2013176","journal-title":"J Clin Invest"},{"key":"432_CR36","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1096\/fj.01-0432com","volume":"15","author":"D Hwang","year":"2001","unstructured":"Hwang D (2001) Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. FASEB J 15:2556\u20132564","journal-title":"FASEB J"},{"key":"432_CR37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","volume":"108","author":"JK Kim","year":"2001","unstructured":"Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI (2001) Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108:437\u2013446","journal-title":"J Clin Invest"},{"key":"432_CR38","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015\u20133025","journal-title":"J Clin Invest"},{"key":"432_CR39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bbrc.2006.05.170","volume":"346","author":"MJ Song","year":"2006","unstructured":"Song MJ, Kim KH, Yoon JM, Kim JB (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346:739\u2013745","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"432_CR40","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2337\/db08-0038","volume":"57","author":"SM Reyna","year":"2008","unstructured":"Reyna SM, Ghosh S, Tantiwong P, Meka CS, Eagan P, Jenkinson CP, Cersosimo E, Defronzo RA, Coletta DK, Sriwijitkamol A, Musi N (2008) Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57(10):2595\u20132602","journal-title":"Diabetes"},{"key":"432_CR41","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db06-1595","volume":"56","author":"DM Tsukumo","year":"2007","unstructured":"Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJ (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986\u20131998","journal-title":"Diabetes"},{"key":"432_CR42","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00125-007-0861-3","volume":"51","author":"MS Radin","year":"2008","unstructured":"Radin MS, Sinha S, Bhatt BA, Dedousis N, O\u2019Doherty RM (2008) Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51:336\u2013346","journal-title":"Diabetologia"},{"issue":"5","key":"432_CR43","doi-asserted-by":"crossref","first-page":"e63983","DOI":"10.1371\/journal.pone.0063983","volume":"21","author":"H Liang","year":"2013","unstructured":"Liang H, Hussey SE, Sanchez-Avila A, Tantiwong P, Musi N (2013) Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS One 21(5):e63983","journal-title":"PLoS One"},{"key":"432_CR44","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/en.2005-0969","volume":"147","author":"H Sell","year":"2006","unstructured":"Sell H, Dietze-Schroeder D, Kaiser U, Eckel J (2006) Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147:2458\u20132467","journal-title":"Endocrinology"},{"key":"432_CR45","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.2337\/db07-1062","volume":"57","author":"I Nieto-Vazquez","year":"2008","unstructured":"Nieto-Vazquez I, Fernandez-Veledo S, de Alvaro C, Lorenzo M (2008) Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes 57:3211\u20133221","journal-title":"Diabetes"},{"issue":"1","key":"432_CR46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcsm.12129","volume":"8","author":"D Verzola","year":"2017","unstructured":"Verzola D, Bonanni A, Sofia A, Montecucco F, D\u2019Amato E, Cademartori V, Parodi EL, Viazzi F, Venturelli C, Brunori G, Garibotto G (2017) Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease. J Cachexia Sarcopenia Muscle 8(1):131\u2013144","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"432_CR47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2011.04.043","volume":"218","author":"RL Roberts","year":"2011","unstructured":"Roberts RL, Van Rij AM, Phillips LV, Young S, McCormick SP, Merriman TR, Jones GT (2011) Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. Atherosclerosis 218(1):123\u2013126","journal-title":"Atherosclerosis"},{"issue":"5","key":"432_CR48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jdiacomp.2015.04.002","volume":"29","author":"I Jialal","year":"2015","unstructured":"Jialal I, Pahwa R (2015) The evolving role of toll-like receptors in diabetic vascular complications. J Diabetes Complications 29(5):617\u2013620","journal-title":"J Diabetes Complications"},{"key":"432_CR49","doi-asserted-by":"crossref","first-page":"105B","DOI":"10.1016\/j.amjcard.2006.11.024","volume":"99","author":"KE Stone","year":"2007","unstructured":"Stone KE, Chiquette E, Chilton RJ (2007) Diabetic endovascular disease: role of coronary artery revascularization. Am J Cardiol 99:105B\u2013112B","journal-title":"Am J Cardiol"},{"issue":"3","key":"432_CR50","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvr238","volume":"92","author":"LL Zhang","year":"2011","unstructured":"Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC (2011) PPAR\u03b3 attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc Res 1 92(3):484\u201393","journal-title":"Cardiovasc Res"},{"issue":"8","key":"432_CR51","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/labinvest.2013.79","volume":"93","author":"Y Pi","year":"2013","unstructured":"Pi Y, Zhang LL, Li BH, Guo L, Cao XJ, Gao CY, Li JC (2013) Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells. Lab Invest 93(8):880\u2013887","journal-title":"Lab Invest"},{"issue":"12","key":"432_CR52","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00109-015-1318-7","volume":"93","author":"MA Carrillo-Sepulveda","year":"2015","unstructured":"Carrillo-Sepulveda MA, Spitler K, Pandey D, Berkowitz DE, Matsumoto T (2015) Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats. J Mol Med (Berl) 93(12):1341\u20131354","journal-title":"J Mol Med (Berl)"},{"issue":"10","key":"432_CR53","doi-asserted-by":"crossref","first-page":"e108844","DOI":"10.1371\/journal.pone.0108844","volume":"10","author":"H Mudaliar","year":"2014","unstructured":"Mudaliar H, Pollock C, Ma J, Wu H, Chadban S, Panchapakesan U (2014) The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. PLoS One 10(10):e108844","journal-title":"PLoS One"},{"issue":"4","key":"432_CR54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jdiacomp.2016.01.014","volume":"30","author":"R Pahwa","year":"2016","unstructured":"Pahwa R, Nallasamy P, Jialal I (2016) Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. J Diabetes Complications 30(4):563\u2013572","journal-title":"J Diabetes Complications"},{"key":"432_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/JOE-12-0338","volume":"216","author":"Z Lu","year":"2013","unstructured":"Lu Z, Zhang X, Li Y, Jin J, Huang Y (2013) TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. J Endocrinol 216:61\u201371","journal-title":"J Endocrinol"},{"issue":"6","key":"432_CR56","first-page":"H732-42","volume":"15","author":"B Dong","year":"2012","unstructured":"Dong B, Qi D, Yang L, Huang Y, Xiao X, Tai N, Wen L, Wong FS (2012) TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes. Am J Physiol Heart Circ Physiol 15(6):H732-42","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"432_CR57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1479-5876-8-133","volume":"15","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Peng T, Zhu H, Zheng X, Zhang X, Jiang N, Cheng X, Lai X, Shunnar A, Singh M, Riordan N, Bogin V, Tong N, Min WP (2010) Prevention of hyperglycemia-induced myocardial apoptosis by gene silencing of Toll-like receptor-4. J Transl Med 15:8:133","journal-title":"J Transl Med"},{"key":"432_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diabres.2016.04.002","volume":"116","author":"M Buraczynska","year":"2016","unstructured":"Buraczynska M, Zukowski P, Ksiazek K, Wacinski P, Dragan M (2016) The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients. Diabetes Res Clin Pract 116:7\u201313","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"432_CR59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1523-1755.2004.00367.x","volume":"65","author":"F Chow","year":"2004","unstructured":"Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH (2004) Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65(1):116\u2013128","journal-title":"Kidney Int"},{"issue":"1","key":"432_CR60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1681\/ASN.2010111210","volume":"23","author":"M Lin","year":"2012","unstructured":"Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC (2012) Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 23(1):86\u2013102","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"432_CR61","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","volume":"55","author":"T Kuwabara","year":"2012","unstructured":"Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Ogawa Y, Imamaki H, Kawanishi T, Ishii A, Koga K, Mori KP, Kato Y, Sugawara A, Nakao K (2012) Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 55(8):2256\u20132266","journal-title":"Diabetologia"},{"issue":"8","key":"432_CR62","doi-asserted-by":"crossref","first-page":"F1145-115","DOI":"10.1152\/ajprenal.00319.2012","volume":"303","author":"H Kaur","year":"2012","unstructured":"Kaur H, Chien A, Jialal I (2012) Hyperglycemia induced Toll like receptor 4 Expression and Activity in Mouse Mesangial cells: Relevance to Diabetic Nephropathy. Am J Physiol Renal Physiol 303(8):F1145-115","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"432_CR63","first-page":"F143-54","volume":"15","author":"H Mudaliar","year":"2013","unstructured":"Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U (2013) The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 15(2):F143-54","journal-title":"Am J Physiol Renal Physiol"},{"key":"432_CR64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MNH.0b013e32803fb767","volume":"16","author":"HJ Anders","year":"2007","unstructured":"Anders HJ, Schl\u00f6ndorff D (2007) Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 16:177\u2013183","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"432_CR65","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/ki.2014.116","volume":"86","author":"D Verzola","year":"2014","unstructured":"Verzola D, Cappuccino L, D\u2019Amato E, Villaggio B, Gianiorio F, Mij M, Simonato A, Viazzi F, Salvidio G, Garibotto G (2014) Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney Int 86(6):1229\u20131243","journal-title":"Kidney Int"},{"key":"432_CR66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2015.09.024","volume":"5","author":"C Wu","year":"2015","unstructured":"Wu C, Lv C, Chen F, Ma X, Shao Y, Wang Q (2015) The function of miR-199a-5p\/Klotho regulating TLR4\/NF-\u03baB p65\/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism. Mol Cell Endocrinol 5:417:84\u201393","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"432_CR67","first-page":"392","volume":"34","author":"J Pirkko","year":"2011","unstructured":"Pirkko J, Pussinen PHD, Aki S, Havulinna MSC, Markku Lehto PHD, Jouko Sundvall MSC, Veikko Salomaa, MD (2011) Endotoxemia Is Associated With an Increased Risk of Incident Diabetes. Diabetes Care 2011 Feb; 34(2): 392\u2013397","journal-title":"Diabetes Care 2011"},{"issue":"9","key":"432_CR68","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/dc09-0467","volume":"32","author":"M Nymark","year":"2009","unstructured":"Nymark M, Pussinen PJ, Tuomainen AM, Forsblom C, Groop PH, Lehto M, FinnDiane Study Group (2009) Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care 32(9):1689\u20131693","journal-title":"Diabetes Care"},{"key":"432_CR69","doi-asserted-by":"crossref","first-page":"e1752","DOI":"10.1038\/cddis.2015.125","volume":"6","author":"P Saurus","year":"2015","unstructured":"Saurus P, Kuusela S, Lehtonen E, Hyv\u00f6nen ME, Ristola M, Fogarty CL, Tienari J, Lassenius MI, Forsblom C, Lehto M, Saleem MA, Groop PH, Holth\u00f6fer H, Lehtonen S (2015) Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway. Cell Death Dis 7 6:e1752","journal-title":"Cell Death Dis"},{"key":"432_CR70","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1046\/j.1523-1755.2001.00725.x","volume":"59","author":"MW Steffes","year":"2001","unstructured":"Steffes MW, Schmidt D, McCrery R, Basgen JM, International Diabetic Nephropathy Study Group (2001) Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104\u20132113","journal-title":"Kidney Int"},{"key":"432_CR71","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002531","volume":"72","author":"D Verzola","year":"2007","unstructured":"Verzola D, Gandolfo MT, Ferrario F, Rastaldi MP, Villaggio B, Gianiorio F, Giannoni M, Rimoldi L, Lauria F, Miji M, Deferrari G, Garibotto G (2007) Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int 72:1262\u20131272","journal-title":"Kidney Int"},{"key":"432_CR72","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s001250051447","volume":"42","author":"TW Meyer","year":"1999","unstructured":"Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42:1341\u20131344","journal-title":"Diabetologia"},{"issue":"6","key":"432_CR73","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1210\/en.2012-2080","volume":"154","author":"JJ Cha","year":"2013","unstructured":"Cha JJ, Hyun YY, Lee MH, Kim JE, Nam DH, Song HK, Kang YS, Lee JE, Kim HW, Han JY, Cha DR (2013) Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology 154(6):2144\u20132155","journal-title":"Endocrinology"},{"issue":"5","key":"432_CR74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ki.2013.11","volume":"83","author":"M Lin","year":"2013","unstructured":"Lin M, Yiu WH, Li RX, Wu HJ, Wong DW, Chan LY, Leung JC, Lai KN, Tang SC (2013) The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy. Kidney Int 83(5):887\u2013900","journal-title":"Kidney Int"},{"issue":"5","key":"432_CR75","doi-asserted-by":"crossref","first-page":"e97985","DOI":"10.1371\/journal.pone.0097985","volume":"19","author":"J Ma","year":"2014","unstructured":"Ma J, Chadban SJ, Zhao CY, Chen X, Kwan T, Panchapakesan U, Pollock CA, Wu H (2014) TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. PLoS One 19(5):e97985","journal-title":"PLoS One"},{"issue":"6","key":"432_CR76","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2014.07.003","volume":"28","author":"I Jialal","year":"2014","unstructured":"Jialal I, Major AM, Devaraj S (2014) Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complications 28(6):755\u2013761","journal-title":"J Diabetes Complications"},{"issue":"9","key":"432_CR77","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1021\/jm401006s","volume":"8","author":"F Peri","year":"2014","unstructured":"Peri F, Calabrese V (2014) Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update. J Med Chem 8(9):3612\u20133622","journal-title":"J Med Chem"},{"key":"432_CR78","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11095-008-9571-x","volume":"25","author":"CG Leon","year":"2008","unstructured":"Leon CG, Tory R, Jia J, Sivak O, Wasan KM (2008) Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases. Pharm Res 25:1751\u20131761","journal-title":"Pharm Res"},{"key":"432_CR79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2007.06.027","volume":"571","author":"T Sha","year":"2007","unstructured":"Sha T, Sunamoto M, Kitazaki T, Sato J, Ii M, Iizawa Y (2007) Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model. Eur J Pharmacol 571:231\u2013239","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"432_CR80","doi-asserted-by":"crossref","first-page":"e54442","DOI":"10.1371\/journal.pone.0054442","volume":"8","author":"U Panchapakesan","year":"2013","unstructured":"Panchapakesan U, Pegg K, Gross S, Komala MG, Mudaliar H, Forbes J, Pollock C, Mather A (2013) Effects of SGLT2 inhibition in human kidney proximal tubular cells\u2013renoprotection in diabetic nephropathy? PLoS One 8(2):e54442","journal-title":"PLoS One"},{"issue":"5","key":"432_CR81","doi-asserted-by":"crossref","first-page":"F1563\u201373","DOI":"10.1152\/ajprenal.90302.2008","volume":"295","author":"D Verzola","year":"2008","unstructured":"Verzola D, Gandolfo MT, Gaetani G, Ferraris A, Mangerini R, Ferrario F, Villaggio B, Gianiorio F, Tosetti F, Weiss U, Traverso P, Mji M, Deferrari G, Garibotto G (2008) Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy. Am J Physiol Renal Physiol 295(5):F1563\u201373","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"432_CR82","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","volume":"123","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia T, Zhu Y, Van Deursen J, Campisi J, Kirkland J (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123(3):966\u2013972","journal-title":"J Clin Invest"},{"key":"432_CR83","doi-asserted-by":"crossref","unstructured":"Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Frumento G, Berruti V, Gandolfo MT, Garibotto G, Deferrari G (2002) Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J Investig Med 50(6): 443\u2013451","DOI":"10.1136\/jim-50-06-04"},{"issue":"Suppl 1","key":"432_CR84","first-page":"S85-7","volume":"15","author":"D Verzola","year":"2004","unstructured":"Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Salvatore F, Berruti V, Gandolfo MT, Garibotto G, Deferrari G (2004) Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells. J Am Soc Nephrol 15(Suppl 1):S85-7","journal-title":"J Am Soc Nephrol"},{"key":"432_CR85","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbrc.2009.07.056","volume":"387","author":"D Verzola","year":"2009","unstructured":"Verzola D, Villaggio B, Procopio V, Gandolfo MT, Gianiorio F, Fam\u00e0 A, Tosetti F, Traverso P, Deferrari G, Garibotto G (2009) Androgen-mediated apoptosis of kidney tubule cells: role of c-jun amino terminal kinase. Biochem Biophys Res Comm 387:531\u2013536, I","journal-title":"Biochem Biophys Res Comm"},{"issue":"2","key":"432_CR86","doi-asserted-by":"crossref","first-page":"C374-80","DOI":"10.1152\/ajpcell.00096.2010","volume":"299","author":"J Satriano","year":"2010","unstructured":"Satriano J, Mansoury H, Deng A, Sharma K, Vallon V, Blantz RC, Thomson SC (2010) Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes. Am J Physiol Cell Physiol 299(2):C374-380","journal-title":"Am J Physiol Cell Physiol"},{"key":"432_CR87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/exmp.2000.2346","volume":"70","author":"G Ding","year":"2001","unstructured":"Ding G, Franki N, Rapasi AA, Reddy K, Gibbons N, Pravin Singhal PC (2001) Tubular cell senescence and expression of TGF-b1 and p21WAF1\/CIP1 in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol 70:43\u201353","journal-title":"Exp Mol Pathol"},{"key":"432_CR88","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1523-1755.2004.00438.x","volume":"65","author":"A Melk","year":"2004","unstructured":"Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF (2004) Expression of p16INK4A and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int 65:510\u2013520","journal-title":"Kidney Int"},{"key":"432_CR89","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40620-014-0136-2","volume":"28","author":"P Tessari","year":"2015","unstructured":"Tessari P (2015) Nitric oxide in the normal kidney and in patients with diabetic nephropathy. J Nephrol 28:257\u2013268","journal-title":"J Nephrol"},{"key":"432_CR90","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40620-016-0362-x","volume":"30","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Denic A, Rule A (2017) The conundrums of chronic kidney disease and aging. J Nephrol 30:477\u2013483","journal-title":"J Nephrol"},{"key":"432_CR91","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1463-1326.2011.01511.x","volume":"14","author":"RA DeFronzo","year":"2012","unstructured":"DeFronzo RA, Davidson JA, Del PS (2012) The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab 14:5\u201314","journal-title":"Diabetes Obes Metab"},{"key":"432_CR92","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1124\/jpet.113.203869","volume":"345","author":"N Kojima","year":"2013","unstructured":"Kojima N, Williams JM, Takahashi T, Miyata N, Roman RJ (2013) Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats. J Pharmacol Exp Ther 345:464\u2013472","journal-title":"J Pharmacol Exp Ther"},{"key":"432_CR93","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40620-016-0261-1","volume":"29","author":"DE Kohan","year":"2016","unstructured":"Kohan DE, Fioretto P, Johnsson K, Parikh S, Ptaszynska A, Ying L (2016) The effect of dapagliflozin on renal function in patients with type 2 diabetes. J Nephrol 29:391\u2013400","journal-title":"J Nephrol"},{"key":"432_CR94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, Von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinmann B (2016) Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med 375:323\u2013334","journal-title":"N Engl J Med"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-017-0432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:24Z","timestamp":1777564704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/30\/6\/719\/8373365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1007\/s40620-017-0432-8","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]}}}